Elixirr International (ELIX) Competitors GBX 860 -14.00 (-1.60%) As of 10/17/2025 11:54 AM Eastern Add Compare Share Share Competitors Stock AnalysisChartCompetitorsDividendEarningsHeadlinesInsider TradesBuy This Stock ELIX vs. DATA, AFM, YOU, PPHC, RCDO, SAG, FNTL, GTLY, MANO, and MJHShould you be buying Elixirr International stock or one of its competitors? The main competitors of Elixirr International include GlobalData (DATA), Alpha Financial Markets Consulting (AFM), YouGov (YOU), Public Policy (PPHC), Ricardo (RCDO), Science Group (SAG), Fintel (FNTL), Gateley (GTLY), Manolete Partners (MANO), and MJ Hudson Group (MJH). These companies are all part of the "consulting services" industry. Elixirr International vs. Its Competitors GlobalData Alpha Financial Markets Consulting YouGov Public Policy Ricardo Science Group Fintel Gateley Manolete Partners MJ Hudson Group Elixirr International (LON:ELIX) and GlobalData (LON:DATA) are both small-cap industrials companies, but which is the superior investment? We will compare the two businesses based on the strength of their earnings, media sentiment, risk, dividends, profitability, analyst recommendations, institutional ownership and valuation. Does the media refer more to ELIX or DATA? In the previous week, GlobalData had 13 more articles in the media than Elixirr International. MarketBeat recorded 14 mentions for GlobalData and 1 mentions for Elixirr International. Elixirr International's average media sentiment score of 0.10 beat GlobalData's score of 0.07 indicating that Elixirr International is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Elixirr International 0 Very Positive mention(s) 1 Positive mention(s) 0 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral GlobalData 1 Very Positive mention(s) 5 Positive mention(s) 5 Neutral mention(s) 2 Negative mention(s) 1 Very Negative mention(s) Neutral Do insiders and institutionals hold more shares of ELIX or DATA? 13.3% of Elixirr International shares are owned by institutional investors. Comparatively, 17.1% of GlobalData shares are owned by institutional investors. 33.8% of Elixirr International shares are owned by company insiders. Comparatively, 61.0% of GlobalData shares are owned by company insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a company will outperform the market over the long term. Do analysts rate ELIX or DATA? GlobalData has a consensus target price of GBX 227.50, indicating a potential upside of 89.58%. Given GlobalData's stronger consensus rating and higher probable upside, analysts clearly believe GlobalData is more favorable than Elixirr International.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Elixirr International 0 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 0.00GlobalData 0 Sell rating(s) 0 Hold rating(s) 3 Buy rating(s) 0 Strong Buy rating(s) 3.00 Which has better earnings and valuation, ELIX or DATA? GlobalData has higher revenue and earnings than Elixirr International. Elixirr International is trading at a lower price-to-earnings ratio than GlobalData, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioElixirr International£129.72M3.20£17.20M£0.362,399.55GlobalData£302.40M2.83£33.17M£0.026,000.00 Is ELIX or DATA more profitable? Elixirr International has a net margin of 18.83% compared to GlobalData's net margin of 11.96%. Elixirr International's return on equity of 15.21% beat GlobalData's return on equity.Company Net Margins Return on Equity Return on Assets Elixirr International18.83% 15.21% 9.88% GlobalData 11.96%12.99%7.91% Is ELIX or DATA a better dividend stock? Elixirr International pays an annual dividend of GBX 0.16 per share and has a dividend yield of 0.0%. GlobalData pays an annual dividend of GBX 0.03 per share and has a dividend yield of 0.0%. Elixirr International pays out 44.1% of its earnings in the form of a dividend. GlobalData pays out 125.0% of its earnings in the form of a dividend, suggesting it may not have sufficient earnings to cover its dividend payment in the future. Which has more volatility and risk, ELIX or DATA? Elixirr International has a beta of 0.63, meaning that its share price is 37% less volatile than the S&P 500. Comparatively, GlobalData has a beta of 0.58, meaning that its share price is 42% less volatile than the S&P 500. SummaryGlobalData beats Elixirr International on 10 of the 18 factors compared between the two stocks. Get Elixirr International News Delivered to You Automatically Sign up to receive the latest news and ratings for ELIX and its competitors with MarketBeat's FREE daily newsletter. Subscribe Now View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding ELIX and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of LON and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart ELIX vs. The Competition Export to ExcelMetricElixirr InternationalConsulting Services IndustryIndustrials SectorLON ExchangeMarket Cap£415.59M£3.45B£7.86B£2.57BDividend Yield2.07%2.71%4.59%5.32%P/E Ratio2,399.553,922.51283.904,250.18Price / Sales3.20201.751,248.9799,406.89Price / Cash21.2531.8327.9127.90Price / Book3.633.904.798.11Net Income£17.20M£155.55M£790.12M£5.89B7 Day Performance-2.06%-1.19%0.13%-0.62%1 Month Performance4.88%-0.96%1.45%0.88%1 Year Performance25.36%0.58%26.59%126.01% Elixirr International Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)ELIXElixirr InternationalN/AGBX 860-1.6%N/A+23.7%£415.59M£129.72M2,399.55484Dividend CutDATAGlobalData2.6842 of 5 starsGBX 127-0.8%GBX 227.50+79.1%-37.1%£906.12M£302.40M6,350.003,532AFMAlpha Financial Markets ConsultingN/AN/AN/AN/A£591.19M£233.62M3,876.921,051YOUYouGov3.8668 of 5 starsGBX 296+1.5%GBX 662.50+123.8%-36.9%£346.89M£383.90M42,285.711,820Trending NewsEarnings ReportAnalyst ForecastInsider TradePPHCPublic Policy1.0364 of 5 starsGBX 1,067-0.3%GBX 1,300+21.8%+66.0%£268.19M£166.33M-1,185.56367RCDORicardoN/AGBX 430+0.2%GBX 430+2.6%£267.52M£476.20M861.722,978Positive NewsSAGScience Group2.5018 of 5 starsGBX 550.01-0.5%GBX 758+37.8%+20.6%£242.33M£114.15M817.25443Positive NewsFNTLFintelN/AGBX 230-1.7%N/A-16.2%£239.64M£85M3,833.33501GTLYGateleyN/AGBX 124-2.4%N/A-6.1%£166.14M£179.50M12,156.861,068Positive NewsMANOManolete Partners2.1248 of 5 starsGBX 86+0.6%GBX 172+100.0%-11.3%£37.68M£30.48M4,278.6129News CoverageMJHMJ Hudson GroupN/AN/AN/AN/A£26.69M£47.45M-437.50232 Related Companies and Tools Related Companies DATA Alternatives AFM Alternatives YOU Alternatives PPHC Alternatives RCDO Alternatives SAG Alternatives FNTL Alternatives GTLY Alternatives MANO Alternatives MJH Alternatives Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (LON:ELIX) was last updated on 10/18/2025 by MarketBeat.com Staff From Our PartnersHoly ****... This could actually MAGAA new document circulating from Washington is stirring major controversy — one that some say could redefine Am...StocksToTrade | SponsoredBuy alert: Move $1,000 before Tesla’s Optimus launchElon's $1,000,000,000,000 payday Elon Musk just made his biggest insider purchase of Tesla stock ever. He's...Altimetry | SponsoredREVEALED: Something Big Happening Behind White House DoorsWhat I just learned about what’s unfolding in the White House is truly stunning… And you need to see it for...Paradigm Press | SponsoredMelt-up warning Porter Stansberry says this bull market is past the “safe zone” and racing toward an event horizon — and in hi...Porter & Company | SponsoredNvidia’s slow death marchEric Fry just went live with one of his most controversial calls yet: “Sell Nvidia.” While Wall Street has bee...InvestorPlace | SponsoredIf You Keep Cash In A U.S. Bank Account… Read This NOWThe Treasury Department just issued a stunning warning: U.S. banks could lose up to $6.6 trillion of custom...Banyan Hill Publishing | SponsoredTrump’s “Smart Dollar” just went mainstream"I Made Millions in the Tech Boom. Here's Where I'd Put My Money Today" This man has called some of the big...Stansberry Research | SponsoredOut of 18,347 Cryptocurrencies... This is the ONLY OneThe Single Most Undervalued DeFi Protocol You've Never Heard Of If there's one cryptocurrency you should b...Crypto 101 Media | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Elixirr International plc Please log in to your account or sign up in order to add this asset to your watchlist. Share Elixirr International With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
